Paul K. Audhya, Chief Medical Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 16,040 shares at $10.73 ($172K) on 2023-08-18, disclosed to the SEC on 2023-08-21.
Open-market sale of $172k KALV by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.73 | 8,020 | $86K | 50.0% |
| 2 | $10.73 | 8,020 | $86K | 50.0% |
| Total | $10.73 avg | 16,040 | $172K | 100% |
| Filing → |
| KALV | SELL | 2026-05-19 | $28K | — | Filing → |
| KALV | SELL | 2026-04-20 | $54K | — | Filing → |
| KALV | SELL | 2026-02-24 | $167K | — | Filing → |